AURAVAX THERAPEUTICS

Lobbying client · Texas · filed 2025 to 2026

Biopharmaceutical company

$50,000 Reported spend

6 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (69188), not by name.

Firms hired 1

MCALLISTER & QUINN, LLC $50,000 6 filings

Bills named in these filings 1

S 2572
Department of Defense Appropriations Act, 2026

2 filings

Reported by year 2 years

2026 $0 1 filing
2025 $50,000 5 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

SENATE 4

Recent filings 6 total

1TY

MCALLISTER & QUINN, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 20, 2026

View → Q4

MCALLISTER & QUINN, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · Senate · $50,000 income · posted Jan 20, 2026

View → Q3

MCALLISTER & QUINN, LLC

3rd Quarter (July 1 - Sep 30) 2025 · Senate · posted Oct 20, 2025

View → Q2

MCALLISTER & QUINN, LLC

2nd Quarter (Apr 1 - June 30) 2025 · Senate · posted Oct 20, 2025

View → Q1

MCALLISTER & QUINN, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · Senate · posted Oct 20, 2025

View → RR

MCALLISTER & QUINN, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · posted Oct 14, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.